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Background: Anterior cingulate cortex (ACC) dysfunction is implicated in schizophrenia by 
numerous strands of scientiﬁ  c investigation. Functional neuroimaging studies of the ACC in 
schizophrenia have shown task-related hypo-activation, hyper-activation, and normal activation 
relative to comparison subjects. Interpreting these results and explaining their inconsistencies 
has been hindered by our ignorance of the healthy ACC’s function. This review aims to clarify 
the site and magnitude of ACC activations in schizophrenia, and sources of their variation.
Method: 48 studies of mnemonic and executive task-related activations in schizophrenia 
using both positron emission tomography (PET) and functional magnetic resonance imaging 
(fMRI) were analyzed. 
Results:  Abnormal activations in schizophrenia were not restricted to the “cognitive” part of 
the ACC. Hypoactivations were most common, and were found in all types of tasks. Hyperac-
tivations when found, were largely in n-back tasks. 
Conclusions: Hypoactivations cannot be explained by poor performance, more demanding 
control conditions or chronicity of illness alone. Patients on anti-psychotic medication tended to 
show both greater ACC activation and better performance, although whether this is directly due 
to their medication or the resultant reduction in symptoms is unclear. The relationship between 
ACC rCBF and task performance is not straightforward. Future research should better control 
confounding factors and incorporate different levels of difﬁ  culty.
Keywords: functional magnetic resonance imaging, positron emission tomography, schizo-
phrenia, anterior cingulate cortex 
Introduction
Pathology in the anterior cingulate cortex (ACC) is widely believed to have a signiﬁ  cant 
part to play in the disease process of schizophrenia. There is much anatomical and 
physiological evidence for this. Densities of neurons, interneurons, axons and synapses 
have all been found to be abnormal in the ACC’s of people with schizophrenia (Arnold 
and Trojanowski 1996), as has both the micro- and macro- circuitry involving both 
ordinary neurons and neuromodulators (Benes 2000). Abnormal activations are often 
found in the ACC in neuroimaging studies in schizophrenia (see below for references), 
which may then normalise upon administration of antipsychotic medication (Braus 
et al 2002; Ngan et al 2002). 
Currently, however, the functional implications of these pathological ﬁ  ndings 
are unknown. This is largely because realtively little is known of the function of the 
healthy ACC. There are several competing theories about ACC function which we 
shall briefly outline here; they are more extensively reviewed elsewhere (Bush 
et al 2000; Paus 2001; Frackowiak et al 2004; Vogt 2005). Structurally, the ACC is a 
large area of cortex, subdivided into affective (BA 25 and 33, and rostral 32 and 24) 
and cognitive (including caudal BA 32 and 24) divisions (Devinsky et al 1995). The 
ACC has extensive interconnections with other brain areas; the rostral, affective part Neuropsychiatric Disease and Treatment 2007:3(1) 88
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(rCZa) with limbic areas, the caudal, cognitive part (rCZp) 
with prefrontal and motor areas. 
Theories of ACC function tend to concentrate on its 
possible cognitive roles, of which there are many. Its 
proposed cognitive functions are more ‘attentive’ than 
“executive”; these include monitoring for errors, monitor-
ing for conflicting responses, and attention to actions, in 
particular “willed”, non-automated actions (Paus 2001). 
It also seems to provide an important, high-level bridge 
between stimuli and responses; Petit et al (1998) suggest 
that ACC activity during working memory delays reflects 
neither memory nor response preparation per se, but rather 
“a state of preparedness for selecting a motor response 
based on the information held on-line”. Whether the ACC 
performs similar functions in regard to its affective inputs 
is unknown, although it seems that its emotional and cog-
nitive domains are mutually inhibitory (Bush et al 2000). 
What is certain is that ACC is activated by arousal and 
stress, presumably via its projections from the midbrain: 
it receives the highest concentration of dopaminergic 
innervation in primate cerebral cortex (Paus 2001). The 
difficulty of assigning the ACC a particular function 
is illustrated by Paus et al’s (1998) review of 107 PET 
studies. They found that the single most important fac-
tor contributing to ACC activation was the level of task 
difficulty, especially in BA 24/32. It is obvious that this 
variable subsumes a wide variety of monitoring, attentive, 
mnemonic, response, and arousal-related processes. 
Both hypo-activation and hyper-activation of the ACC 
are found in neuroimaging studies of schizophrenia. It could 
be that an abnormal ACC in schizophrenia is hyperactive at 
rest, but is unable to activate further in response to increas-
ing task demands, thereby becoming relatively hypoactive. 
Such a relationship has been found in the medial temporal 
lobe in schizophrenia (Honey et al 2003). Manoach (2003) 
has described this relationship in the dorsolateral prefrontal 
cortex (DLPFC) in schizophrenia, and relates task-related 
DLPFC hypoactivity to decreased task performance. Other 
imaging studies in schizophrenia, however, have found that 
the ACC is hypoactive, not hyperactive, at rest (Siegel et al 
1993; Haznedar et al 1997). Investigators have also looked 
at the effect of antidopaminergic medications on the ACC’s 
activation patterns. Reductions in cortical dopaminergic 
neurotransmission cause a reduction in resting ACC hy-
peractivity (Ngan et al 2002), and a normalization of task-
related ACC hypoactivity (Fletcher et al 1996). Such effects 
are signiﬁ  cant as they may eventually demonstrate a link 
between dopamine dysfunction, abnormal ACC activation, 
impaired task performance and their correction by neuroleptic 
medications in schizophrenia. 
The ACC does not always show a task-related hypoac-
tivation; indeed, it can be hyperactive (see Results). This 
inconsistency may be due to a large number of variables. 
These include: different cognitive demands made by different 
tasks, how well subjects perform the task, the nature of the 
control task, whether subjects are on typical, atypical or no 
medication, and whether subjects are acutely psychotic or 
chronically ill. It has also been suggested that the scanning 
time (longer in PET than fMRI) may make a difference, if 
people with schizophrenia become hyperactive at the start 
of the task and then slump into hypoactivity (Callicott 
et al 2000). It is also worth remembering that just because 
an area shows neither hyper- nor hypoactivation, it does 
not imply that that area is doing its normal job perfectly 
satisfactorily.
Functional neuroimaging experiments in schizophrenia 
tend to fall into two broad categories. These are: 
1.  Imaging patients performing cognitive psychological 
tests, ﬁ  nding areas of abnormal activation, and trying to 
relate these to anatomical or behavioral abnormalities. 
2.  Imaging patients with speciﬁ  c symptoms, to try to ﬁ  nd 
the physiological basis for those symptoms (especially 
auditory verbal hallucinations). 
This review will concentrate on a subset of the ﬁ  rst cat-
egory of experiments, so that valid comparisons between 
experiments can be made. It will ignore work in the ﬁ  elds 
of: eye movements, facial, and emotional processing, oddball 
target detection, logic/decision-making, theory of mind, and 
symptom-based experiments because we wish to concentrate 
on tasks with a mainly cognitive basis that have been pub-
lished in signiﬁ  cant numbers. 
The review has two broad aims; one anatomical, the 
other functional. First, it examines the sites of functional 
abnormality in a range of imaging experiments to see whether 
they localise to one or more particular areas of ACC. Sec-
ond, it attempts to clarify the reasons why ACC activation 
may vary from one experiment to the next. One ﬁ  nal point 
regarding “activations” must be clariﬁ  ed. fMRI can only 
compare relative changes in activations, eg, patients (task 
activation—control activation)—comparison subjects (task 
activation—control activation). It cannot compare absolute 
activations, eg, patients (task activation)—comparison sub-
jects (task activation). PET can compare both relative and 
absolute activations. 
When the terms “hyperactivation” or “hypoactivation” 
are used in this paper, these refer to relative changes in Neuropsychiatric Disease and Treatment 2007:3(1) 89
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activation, not absolute activations. Indeed, when a schizo-
phrenia cohort is said to show task-related hypoactivity, their 
average brain activation during the task may well be higher 
than that of comparison subjects. 
The review sets out to examine the following aspects of 
ACC activations:
Location
Areas of abnormal activation during cognitive tasks may 
congregate in the “cognitive” domain of the ACC (rCZp), the 
affective domain of the ACC (rCZa), or may be distributed 
throughout. 
Direction
The ACC may be hypoactive, hyperactive or of normal acti-
vation during task performance in schizophrenia.
Relationship to performance/other 
variables
Abnormal activity in schizophrenia may be associated with 
impaired task performance, chronicity of illness, type of task, 
current symptoms, or scanning method. 
Effect of anti-psychotic medication on 
ACC activity and task performance
Administration of anti-psychotic medication may normalise 
(ie increase or decrease), hyperactivate, or hypoactivate the 
ACC during task performance. Medication may also alter 
task performance itself. 
Method
Papers were selected from the PubMed database (www.ncbi.
nlm.nih.gov/entrez/query.fcgi) from January 1990 to July 
2005 using the following search terms: 
•  Schizophrenia AND fMRI
•  Schizophrenia AND functional magnetic
•  Schizophrenia AND PET
•  Schizophrenia AND positron emission
Of these papers, those using ﬂ  uorinated deoxyglucose (FDG) 
were eliminated as we wished to concentrate on studies which 
employed measures of activation inferred from regional 
blood ﬂ  ow. Studies of mnemonic tasks (2-back or encod-
ing/recognition/retrieval tasks), and studies of executive 
functions (the Stroop, verbal ﬂ  uency, Stop or Go-No-Go, 
and Continuous Performance tasks), 49 altogether, were 
selected from the remaining (69) papers. Unfortunately, 
formal meta-analysis was precluded because of insufﬁ  cient 
and inconsistent reporting of useable summary data, and the 
diverse methodologies employed. The results are therefore 
represented in a simple, vote-counting style. 
Results
Results of these 49 studies are tabulated below (Tables 1–4). 
The sites of normal and abnormal activations of ACC in the 
memory and executive experiments are shown in Figures 
2 and 3, respectively. Regarding ACC activations, one can 
make the following comments:
Location
All of the points of maximal activation in comparison 
subjects in both mnemonic and executive tasks lie in rCZp 
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Figure 1 This graph illustrates how schizophrenic subjects might show a relative task-related hypoactivation, while being hyperactive in absolute terms. Neuropsychiatric Disease and Treatment 2007:3(1) 90
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(Figures 2 and 3). The areas of over- and underactivity in 
schizophrenia are less congregated. The Go/NoGo and ver-
bal ﬂ  uency hypoactivation points cluster in rCZa and rCZp 
respectively, but the points of differential activation in the 
other tasks are distributed throughout the ACC. 
Direction
The ACC was found to be hypoactive in schizophrenia much 
more often than it was hyperactive (16/49 and 6/49 experi-
ments, respectively). 
Relationship to performance/other 
variables
Possible factors affecting ACC activation include: task 
performance, the cognitive requirements of both the experi-
mental and control tasks, length of illness, scanning times 
(PET taking longer than fMRI), and patients’ medication 
status. 
In 9/14 of the hypoactivations, the schizophrenic subjects’ 
performance was equal to that of the controls. There were 
hypoactivations in all of the tasks, and hyperactivations in 
three (four in the n-back, and one each in the recognition 
and Stroop tasks). 4/17 studies of patients with illness of <6 
years showed a hypoactive ACC, compared with 8/26 stud-
ies of patients with illness of >6 years. 13/17 short-illness 
patient groups performed worse than comparison subjects, 
compared with 15/26 long-illness patient groups, an indica-
tion that the younger patients were more psychotic and hence 
more impaired. 6/42 fMRI studies showed hyperactivations, 
versus 0/14 PET studies. 
Medication effects
All of the ACC hyperactivations reviewed here occurred in 
patients taking anti-psychotic medication. Medicated patients 
also exhibited proportionally less hypoactivations (10/44) 
than unmedicated ones (5/11), and less poor performances 
(26/46 vs 9/11). Being on an atypical rather than a typical 
antipsychotic seemed to marginally improve performance 
(11/25 did worse on an atypical, 6/9 on a typical), but made 
no difference to the number of hypoactivations (if anything, 
increasing them from 1/9 to 6/25). 
Discussion
Before speculating upon why the schizophrenia patients’ 
ACC might be both over- and underactive, one must ask 
two questions about ACC activation in normal subjects. 
The ﬁ  rst is anatomical: how do the areas of abnormal ACC 
activation in schizophrenia compare with those areas acti-
vated in normal subjects performing the same tasks? The 
second is functional: what is the putative role of the normal 
ACC in mnemonic and executive tasks? The ﬁ  rst question 
is important because abnormal neural circuitry in schizo-
phrenia may alter the brain’s functional neuroanatomy: both 
how and where information is processed may change. Tasks 
may even be carried out in different ways. In an insightful 
review of prefrontal dysfunction in working memory tasks in 
schizophrenia, Manoach (2003) points out that the common 
ﬁ  nding of schizophrenic hypofrontality may merely reﬂ  ect 
more variable and more disparate cortical activations, and 
not decreased cortical activation. 
The points of maximal activation in comparison sub-
jects during all of the cognitive tasks reviewed here lie in 
rCZp (Figures 2 and 3). Contrary to expectations, areas of 
abnormal activation within schizophrenics’ ACC’s were not 
conﬁ  ned to rCZp. This does not support Manoach’s (2003) 
theory that activations in schizophrenia are more widespread, 
however, as there are far more hypoactivations (10) than 
hyperactivations (2) in rCZa. Rather, this review agrees with 
the meta-analysis of Hill et al (2004), which proposes that 
frontal activations in schizophrenia are generally lower, but 
not more disparate. 
Regarding the second question, the ACC’s role in both 
mnemonic and executive tasks is unclear. Its proposed roles 
in attention and in holding information online in order to 
make a response (Petit et al 1998) are obviously highly rel-
evant to working memory tasks like the n-back. Desgranges 
et al’s review (1998) notes that ACC activation is “almost 
constant” in episodic memory tasks, including encoding, 
recognition and retrieval, which they put down to its many 
proposed cognitive roles. Likewise, Ragland et al (2000) 
explain ACC activation during recognition with reference 
to its information-holding, monitoring and response selec-
tion capacities. A primate ACC lesion study implies that the 
ACC is more important for task performance in general than 
working memory speciﬁ  cally (Rushworth et al 2003). Indeed, 
Peterson et al (1999) claim that it is involved in almost all 
stages of an executive task (the Stroop).
We may now ask why, in schizophrenia, the ACC can 
be both hyper- and hypoactive? When frontal hypoactivity 
is found in association with impaired performance, it can be 
argued that either a frontal abnormality impaired performance, 
or that the subjects “gave up” on the task, leading to frontal 
hypoactivity (Frith et al 1995). If decreased task performance 
were responsible for hypoactivity, one would expect that 
subjects would perform worse on those tasks in which they Neuropsychiatric Disease and Treatment 2007:3(1) 91
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showed ACC hypoactivity (as was predicted in the introduc-
tion). But this was not observed consistently. It therefore 
seems unlikely that task performance accounts for the observed 
activations. ACC hypoactivations do not appear to be related 
to particular tasks, whereas hyperactivations do. This ﬁ  nding 
echoes Glahn et al’s (2005) meta-analysis which showed the 
ACC to be regularly hyperactive in n-back tasks. The reason 
for this is uncertain. One might argue that this demonstrates 
a hyperactive tendency in mnemonic tasks, but as the n-
back task also makes considerable executive demands, this 
conclusion would not be valid. Task-related hypoactivity could 
be an artefact of the subtraction of a large control activation 
from a normal task-related activation. Unfortunately, none of 
the PET experiments compared control-related activations, 
so one cannot dismiss this possibility. In the majority of the 
encoding/retrieval/recognition experiments showing ACC hy-
poactivity, however, the control task was just “REST”, which 
makes minimal demands on an attentional/task-monitoring 
system. In fact, the n-back control (a 0-back task) requires 
much more attention and response preparation, but in this case 
the task-control subtraction gave several hyperactive results. 
The Go/NoGo task is the only one in which it is pos-
sible that a hyperactive control condition was responsible 
for an overall hypoactive Task-Control subtraction. Here, 
N-back task: hyperactivity (schizophrenics [Sz] - comparison subjects [CS])
N-back task: hypoactivity (Sz - CS) 
N-back task: mean activation site in meta-analysis of normals (Owen et al 2005)
N-back task: mean site of hyperactivity in the Sz - CS condition (meta-analysis of Glahn et al 2005) 
Encoding/Recognition/Retrieval task: hyperactivity (Sz - CS) 
Encoding/Recognition/Retrieval task: hypoactivity (Sz - CS) 
E/R/R: site of mean activation for working memory of spatial positions/faces (Petit et al 1998)
Figure 2 Sites of hyperactivation and hypoactivation in schizophrenia and mean activation in controls during mnemonic tasks (n-back and encoding, recognition and 
retrieval tasks). Most experiments gave just one point of maximal activation in the ACC but a few gave more.  All are listed in Tables 1–3.  The points anterior to the dashed 
grey line lie in rCZa, those posterior to the line lie in rCZp. Neuropsychiatric Disease and Treatment 2007:3(1) 92
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the only experiment in which the ACC was not hypoactive 
was the one in which the patients performed worse than the 
controls, hence, in the other three sets of experiments the 
patients may have been “trying harder” throughout, lead-
ing to hyperactivations during the control condition and an 
apparent overall hypoactivity. 
Callicott et al (2000) mention the possibility that scan-
ning time could affect the activation result if schizophrenia 
patients’ activations started off hyperactive and then became 
hypoactive. As PET scans last longer, it would average a 
lower activation than fMRI if they both began at the start of 
the experiment. Although none of the 14 PET experiments 
showed a hyperactivation, only 6 of the 42 fMRI experiments 
did, so, without greater numbers of PET studies, one cannot 
attribute this distribution to scanning method. 
Hill et al (2004), in their review of hypofrontality in 
schizophrenia, found that increased length of illness was 
the biggest contributor to hypofrontality, although they were 
careful to point out that increased age is a confound which 
is very difﬁ  cult to factor out. Age is an especially important 
factor when considering ACC activation, as Buchsbaum et al 
(1997) found that the ACC is one of two brain areas showing 
the greatest age-related metabolic decline in healthy subjects. 
This observation led Schultz et al (2002) to dismiss their ﬁ  nd-
ing that the ACC’s rCBF declines in proportion to duration 
of schizophrenic illness as an age-related effect. 
Stroop task: approximate centre of activation found by meta-analysis of Stroop tasks in normals (Neumann et al 2005)
Verbal fluency: hypoactivation (Sz - CS) 
Verbal fluency: area responding most to increasing VF task difficulty in normals (Fu et al 2002) 
Go-NoGo: hypoactivation (Sz - CS)
Go-NoGo: maximal area of activation in normals during error processing (Menon et al 2001)
CPT: area of delay-related activation in both normals and Sz’s (Barch et al 2001)
Stroop task: hypoactivation (schizophrenics [Sz] – comparison subjects [CS])
Stroop task: hyperactivation (Sz - CS)
Figure 3 Sites of hyperactivation and hypoactivation in schizophrenia and mean activation in controls during executive tasks (the Stroop, Verbal Fluency, Go-NoGo and 
Continuous Performance tasks). Most experiments gave just one point of maximal activation in the ACC but a few gave more.  All are listed in Tables 1–3.  The points ante-
rior to the dashed grey line lie in rCZa, those posterior to the line lie in rCZp.Neuropsychiatric Disease and Treatment 2007:3(1) 93
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This review found no evidence that longer illness leads to 
a more hypoactive ACC. There is a probable confound pres-
ent, however, as the short-illness patient groups performed 
worse than the long-illness patient groups, an indication that 
the younger patients were more psychotic and hence more 
impaired. If acute psychosis were also associated with task-
related ACC hypoactivation, this would mask a chronicity 
effect, as both younger, more psychotic patients and older, 
chronic patients would hypoactivate. Unfortunately there 
was insufficient information about patients’ symptoms 
given in many studies, so this factor could not be assessed 
independently. 
The relationship between rCBF and anti-psychotic medi-
cations is a complex and poorly characterized one. It is also 
uncertain what changes in rCBF mean in terms of underlying 
brain activity, for instance, whether an increase implies that 
the brain is doing its job more productively or less efﬁ  ciently. 
To help decide this, one must compare schizophrenic brain 
activity (and task performance) pre- and post-medication 
with that of normal subjects, both at rest and during tasks. 
It is a common ﬁ  nding that anti-psychotics increase rCBF 
in the striatum and parts of the frontal cortex, both at rest 
(Lahti et al 2003; Sharaﬁ   et al 2005) and during a task (Jones 
et al 2004), although this is not always the case (either at 
rest—Miller et al 2001; or during a task—Liddle et al 2000). 
Atypical anti-psychotics are thought to increase rCBF more 
than typical anti-psychotics in the prefrontal cortex (Honey 
et al 1999), including the ACC (Lahti et al 2003). Lahti 
et al (2004) found that clozapine increased ACC activation 
in schizophrenics performing an auditory discrimination 
task, and that this increase was a normalization of activity, 
not a hyperactivation. 
Although most conclude that the increased frontal rCBF 
must be cognitively beneﬁ  cial, it has been difﬁ  cult to show 
a concomitant increase in task performance (Honey et al 
1999; Jones et al 2004), despite the abundant evidence that 
treatment with atypical anti-psychotics does improve perfor-
mance, eg, at verbal ﬂ  uency tasks and the Stroop (Velligan 
et al 2002) and at a CPT and a spatial working memory task 
(Harvey et al 2003). It is not just atypical anti-psychotics that 
present this problem, however. Schizophrenics treated with 
cognitive enhancers also show increases in prefrontal (Nahas 
et al 2003) and ACC activity (Spence et al 2005) during task 
performance, but fail to demonstrate an increased aptitude 
for the task. It is therefore interesting to note that all of the 
ACC hyperactivations reviewed here occurred in patients 
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Figure 4  A graph illustrating one possible relationship between ACC activity, task difﬁ  culty and schizophrenia.  Adapted from Manoach’s (2003) theory of DLPFC activation 
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taking anti-psychotic medication. Medicated patients also 
showed less hypoactivations and better performance, and 
those on atypical medication performed best of all. As all 
of the hyperactivations occurred in fMRI experiments, one 
cannot be sure whether the greater task-related activation 
in schizophrenics was due to a lower resting activation or a 
higher task-related activation (or both). As anti-psychotics 
are thought to increase frontal rCBF, one must presume the 
latter. Unfortunately, as was the case with the length of ill-
ness, these data might well be confounded with the patients’ 
current symptoms. Nevertheless, a patient’s medication status 
must remain of prime importance when one seeks to interpret 
their ACC activation state. 
Investigators have attempted to explain the inconsistency 
of frontal activation ﬁ  ndings in schizophrenia in several 
ways. I shall address two questions on this subject: why ACC 
activations vary (from hyper- to hypo-) between experiments, 
and why prefrontal activations vary (from hyper- to hypo-, 
and from location to location) within experiments. Mano-
ach (2003) and Callicott et al (2003) have both put forward 
theories as to why the DLPFC can be both hyperactive and 
hypoactive in schizophrenia. It would be interesting to see 
if these theories could also explain the behavior of the ACC. 
Manoach (2003) proposes that both variable DLPFC activa-
tions and inconsistent relationships of DLPFC activation 
to performance (from direct to inverse, or neither) can be 
explained by one theory. This states that the normal DLPFC 
increases its activation in response to increasing task demand 
up to a maximum point, after which both DLPFC activa-
tion and performance decline. Manoach (2003) proposes 
that in schizophrenia, the same relationship exists, but with 
its maximal activation and performance at a lower level of 
task demand, ie the curve is shifted to the left. Would this 
relationship in the ACC explain the pattern of activations we 
have seen? The answer is no. Lahti et al (2004) claim that, 
in schizophrenic patients, clozapine reduces resting ACC 
hyperactivity and increases task-related activity, ie, it shifts 
the curve (illustrated in Figure 4) to the right. This would 
certainly be an important ﬁ  nding, as it relates task difﬁ  culty 
and ACC activation to each other and demonstrates how 
antipsychotic medication may change them. 
There are two problems with this conclusion. The ﬁ  rst 
is as follows: at high levels of task difﬁ  culty, patients’ 
ACC’s become comparatively hypoactive. If one assumes 
(as Manoach’s (2003) model of the DLPFC does) that task 
performance declines once the ACC becomes hypoactive, 
then one must conclude that whenever the ACC is hypoactive, 
performance must similarly decline. In this review, however, 
9/19 experiments showed ACC hypoactivity and identical 
performance, compared with 5/29 experiments showing 
ACC hypoactivity and impaired performance. Performance 
obviously has a much more complex relationship with rCBF 
than this graph indicates. 
The second problem is that if medication does shift the 
curve to the right, then one would expect that patients taking 
anti-psychotic medications would show less ACC hyperactivations 
Table 4 Overall results
  Medication  Sz Performance  Relative ACC activations in 
     schizophrenia
Medicated  47 on  26/47 worse   6↑, 10↓ 
Non-medicated  11 off  9/11 worse  5↓ 
Medicated (typical)  9  6/9 worse  2↑, 1↓
Medicated (atypical)  25  11/25 worse  3↑, 6↓
 17  on    3↑, 7↓
Equal performers         19  2 off    2↓
  21 on     3↑, 2↓
Worse performers         30  9 off    3↓ 
Illness < 6 yrs  10 on, 7 off  4/17 same
   13/17  worse  1↑, 4↓
Illness > 6 yrs  24 on, 2 off  15/26 same
   11/26  worse  3↑, 8↓
PET                     15      6↓
fMRI                    42       6↑, 10↓
Notes: When there was insufﬁ  cient information given in a study to assign it to a particular group, it was left out of the total; eg, there were 47 studies involving medicated 
patients, but only 34 of these speciﬁ  ed that their patients were all on typical or atypical neuroleptics, hence the remaining 13 studies are not included in the medicated 
(typical) and medicated (atypical) subtotals. 
Abbreviations: on/off, on or off neuroleptics; ACC, anterior cingulate cortex.Neuropsychiatric Disease and Treatment 2007:3(1) 98
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in response to tasks, not more. The opposite relationship ex-
ists, however, as all 6 hyperactivations occurred in those on 
medication, not off. A possible objection to this point could 
be that medication might shift the curve upwards (ie activating 
the ACC more at all levels of difﬁ  culty) and not to the right, 
this, however, is not what Lahti et al (2004) found. A further 
objection would be that if a narrow window of task difﬁ  culties 
near the intersection of the two curves were being examined, 
a rightward shift in the schizophrenics’ curve would indeed 
lead to more ACC hyperactivations, not less. But this theory 
would also predict that the ACC should be hyperactive in un-
medicated schizophrenics not engaged in tasks (a window of 
difﬁ  culty at the left end of the graph), yet it has been shown to 
be hypoactive in two studies with a combined patient number 
of 120 (Siegel et al 1993; Haznedar et al 1997).
Callicott et al (2003) have a different explanation for the 
mixture of prefrontal hyperactivations and hypoactivations, 
which also relates to the second question under consideration 
here: why prefrontal activation varies so widely within ex-
periments. They point out that in order to support Manoach’s 
(2003) model, data must show that a speciﬁ  c region moves 
from hyperactivity to hypoactivity as performance falls. This 
has not yet been achieved. Another possibility is that there are 
many areas of hyper- and hypoactivity throughout the frontal 
cortex, which remain relatively hyperactive or hypoactive, 
with their absolute activation varying with performance (and, 
it could be added, medication status). They therefore divide 
their patients into two broad groups. The ﬁ  rst group dem-
onstrate a mixture of hyperactivations and hypoactivations 
throughout prefrontal cortex whilst maintaining similar task 
performance to that of controls. The second group are much 
more uniformly “hypofrontal”, with poorer task performance 
than that of controls. Whether these hypothetical patient types 
can be related to other variables such as length of illness or 
current symptoms remains to be seen. 
There is insufﬁ  cient evidence here to support or deny 
Callicott et al’s proposition—one would have to look at 
individual patients’ results. Their model is consistent with 
the observation that taking antipsychotic medication may 
normalise or even lead to overactivation of some schizo-
phrenic patients’ ACC’s which ordinarily cannot activate 
sufﬁ  ciently. In some, performance may be maintained by 
recruiting larger prefrontal areas or “hyperactivating” those 
already in use; in others, this may not be possible, and so 
performance will suffer. As to why ACC activation does 
not appear to be proportional to task performance, one must 
conclude that the ACC is obviously not the most important 
brain area involved in the task. 
Finally, this review must be put into context. Despite 
much experimentation, relatively little is known about the 
cognitive function of the ACC in either healthy volunteers or 
schizophrenia patients. Even less is known about the ACC’s 
emotional or limbic roles, least of all how these may be 
compromised in schizophrenia. Numerous imaging studies 
have shown the ACC to be hyperactive in schizophrenics 
during auditory verbal hallucinations (Silbersweig et al 1995; 
Shergill et al 2000; Copolov et al 2003) and passivity phe-
nomena (Spence et al 1997), although whether this reﬂ  ects 
an attentional or a generative process is uncertain. Damasio 
(1999) believes that the ACC is largely responsible for “core 
consciousness” (consciousness without its autobiographical 
component), as it receives both external and internal sensory 
input, which would allow it to map images of external objects, 
images of the body, and the former’s effect on the latter. As 
object images are associated with possible motor responses, 
he also proposes that it produces our sense of agency, that 
“these images are mine and I can act on the object that caused 
them” (Damasio 1999). The potential importance of ACC 
pathology in schizophrenia, therefore, is clear. A malfunc-
tioning ACC may underlie the disconnection of world, self, 
and action which is the hallmark of psychosis. It is therefore 
signiﬁ  cant that the administration of sufﬁ  cient ketamine to 
reactivate psychotic hallucinations and delusions in stable 
schizophrenic patients is associated with increased ACC 
rCBF (Lahti et al 1995). Any ACC contribution to mere 
cognitive dysfunction in schizophrenia may be just the tip 
of the iceberg. 
In conclusion, one may make the following points about 
abnormal ACC activations in schizophrenia.
•  Location
  Points of maximal activation in normal subjects perform-
ing both mnemonic and executive tasks all lie in rCZp. 
Points of abnormal activations (hyper- and hypo-) dur-
ing mnemonic or executive tasks in schizophrenia are 
documented in over one third of experiments, and lie in 
both rCZa and rCZp. 
•  Direction
  Hypoactivations outnumbered hyperactivations by 
around two to one. Hypoactivations were found in 
all tasks (the n-back, encoding, recognition, retrieval, 
Stroop, CPT, verbal fluency and Go/NoGo tasks). 
Hyperactivations were largely conﬁ  ned to the n-back 
task (4/6).
•  Relationship to performance/other variables
  Hypoactivations are unlikely to be due to (or even 
associated with, in most cases) poor performance. Neuropsychiatric Disease and Treatment 2007:3(1) 99
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The ACC may be regularly hypoactive during 
Go/NoGo tasks due to a more demanding control 
condition. There is no evidence that chronicity of 
illness increases task-related ACC hypoactivation, 
although it is possible that those with ACC hypoactiv-
ity due to acute psychosis are masking this effect here. 
These results do not support the application of Manoach’s 
(2003) model of DLPFC dysfunction in schizophrenia to 
the ACC, as the model would explain neither the variable 
ACC activations nor the relationship of ACC activation 
to task performance.
•  Effect of anti-psychotic medication
  Patients on medication performed better and showed greater 
ACC activation (less hypoactivations and more hyperactiva-
tions), although symptomatology may confound this result. 
Those on atypical anti-psychotics performed best of all, 
despite showing more hypoactivations. 
  This point illustrates a common difﬁ  culty in linking 
increases in rCBF to improvements in performance, and 
suggests that the relationship between rCBF and perfor-
mance is not a straightforward one. 
Future directions 
Clearly future studies must include larger numbers of par-
ticipants so that potential confounds between patients and 
controls may be controlled in the analysis or by stratiﬁ  cation. 
In terms of meta-analysis, it would be greatly beneﬁ  cial to the 
ﬁ  eld if authors reported clinical and imaging parameters more 
consistently. The use of the same test materials including 
baseline task is another obvious issue which would aid data 
pooling and analysis. Finally, there is also a need to develop 
generally accepted standards for reporting fMRI data which 
includes areas of brain activation as probabilistic maps in 3 
dimensions (see Costafreda et al 2006). 
Limitations
This study looks at a wide selection of experiments which 
make a variety of cognitive demands. It was therefore 
designed as a simple comparative work, and not as a complex 
meta-analysis. This design obviously limits the interpreta-
tive capacity of the study, especially as studies with positive 
ﬁ  ndings which do not quite reach statistical signiﬁ  cance are 
not included in the totals (eg, there may be non-signiﬁ  cant 
ACC hyperactivity in other tasks besides the n-back). It was 
also felt that performing simple post-hoc statistical tests 
(eg, the chi-square test) would add little to the reliability of 
the conclusions. Overall, this study was not intended to be 
a deﬁ  nitive examination of the ACC in cognitive tasks in 
schizophrenia, but merely to raise important questions for 
further studies. 
Acknowledgments
Dr Rick Adams would like to thank Prof Chris Frith for advice 
on subject matter and for commenting on an early draft. 
References
Arnold SE, Trojanowski JQ. 1996. Recent advances in deﬁ  ning the neuropa-
thology of schizophrenia. Acta Neuropathol, 92:217–31.
Artiges E, Martinot J-L, Verdys M, et al. 2000. Altered hemispheric func-
tional dominance during word generation in negative schizophrenia. 
Schizophr Bull, 26:709–21.
Barbas H. 2000. Connections underlying the synthesis of cognition, 
memory and emotion in primate prefrontal cortices. Brain Res Bull, 
52:319–30.
Barch DM, Carter CS, Braver TS, et al. 2001. Selective deﬁ  cits in prefrontal 
cortex function in medication-naïve patients with schizophrenia. Arch 
Gen Psychiatry, 58:280–8.
Barch DM, Csernansky JG, Conturo T, et al. 2002. Working and long-
term memory deﬁ  cits in schizophrenia: is there a common prefrontal 
mechanism? J Abnorm Psychol, 111:278–494.
Benes FM. 2000. Emerging principles of altered neural circuitry in schizo-
phrenia. Brain Res Rev, 31:251–69.
Boksman K, Theberge J, Williamson P, et al. 2005. A 4.0-T fMRI study of 
brain connectivity during word ﬂ  uency in ﬁ  rst episode schizophrenia. 
Schizophr Res, 75:247–63.
Bonner-Jackson A, Haut K, Csernansky JG, et al. 2005. The inﬂ  uence of 
encoding strategy on episodic memory and cortical activity in schizo-
phrenia. Biol Psychiatry, 58:47–55. 
Braus DF, Ende G, Weber-Fahr W, et al. 2002. Functioning and neuronal 
viability of the anterior cingulate cortical neurons following antipsy-
chotic treatment: MR-spectroscopic imaging in chronic schizophrenia. 
Eur Neuropsychopharmacology, 12:145–52.
Buchsbaum MS, Hazlett EA. 1997. Functional brain imaging and aging in 
schizophrenia. Schizophr Res, 27:129–41.
Bush G, Luu P, Posner MI. 2000. Cognitive and emotional inﬂ  uences in 
anterior cingulate cortex. Trends Cogn Sci, 4:215–22. 
Cabeza R, Nyberg L. 2000. Neural bases of learning and memory: functional 
neuroimaging evidence. Curr Op in Neurol, 13:415–21. 
Callicott JH, Bertolino A, Mattay VS, et al. 2000. Physiological dysfunction 
of the dorsolateral prefrontal cortex in schizophrenia revisited. Cereb 
Cortex, 10:1078–92. 
Callicott JH, Mattay VS, Verchinski BA, et al. 2003. Complexity of 
prefrontal cortical dysfunction in schizophrenia: more than up or down. 
Am J Psychiatry, 160:2209–15.
Carter CS, Mintun M, Nichols T, et al. 1997. Anterior cingulate gyrus dys-
function and selective attention deﬁ  cits in schizophrenia: [15O]H2O 
PET study during single-trial Stroop task performance. Am J Psychiatry, 
154:1670–5.
Copolov DL, Seal ML, Maruff P, et al. 2003. Cortical activation associ-
ated with the experience of auditory hallucinations and perception of 
human speech in schizophrenia: a PET correlation study. Psychiatry 
Res, 122:139–52. 
Costafreda S, Fu CHY, Lee L, et al. 2006. A systematic review and quantita-
tive appraisal of fMRI studies of verbal ﬂ  uency: role of the left inferior 
frontal gyrus. Hum Brain Mapp, 27:799–810.
Crespo-Facorro B, Paradiso S, Andreasen NC, et al. 2001. Recalling word 
lists reveals “cognitive dysmetria” in schizophrenia: a positron emission 
tomography study. Am J Psychiatry, 156:386–92.
Crespo-Facorro B, Wiser AK, Andreasen NC, et al. 2001. Neural basis of 
novel and well-learned recognition memory in schizophrenia: a positron 
emission tomography study. Hum Brain Mapp, 12:219–31.Neuropsychiatric Disease and Treatment 2007:3(1) 100
Adams and David
Curtis VA, Bullmore ET, Brammer MJ, et al. 1998. Attenuated frontal 
activation during a verbal ﬂ  uency task in patients with schizophrenia. 
Am J Psychiatry, 155:1056–63. 
Damasio AR. 1999. The feeling of what happens: body, emotion and the 
making of consciousness. New York: Harcourt Pr.
Desgranges B, Baron J-C, Eustache F. 1998. The functional neuroanatomy 
of episodic memory: the role of the frontal lobes, the hippocampal 
formation, and other areas. Neuroimage, 8:198–213. 
Devinsky O, Morrell MJ, Vogt BA. 1995. Contributions of anterior cingulate 
cortex to behaviour. Brain, 118:279–306. 
Dolan RJ, Fletcher PC, McKenna P, et al. 1999. Abnormal neural integration 
related to cognition in schizophrenia. Acta Psychiatr Scand, 99(Suppl 
395):58–67.
Dye SM, Spence SA, Bench CJ, et al. 1999. No evidence for left supe-
rior temporal dysfunction in asymptomatic schizophrenia and bipolar 
disorder. Br J Psychiatry, 175:367–74.
Erkwoh R, Sabri O, Schrekenberger M, et al. 2002. Cerebral correlates of 
selective attention in schizophrenic patients with formal thought disor-
der: a controlled H2 150-PET study. Psychiatry Res, 115:137–53.
Eyler LT, Olsen RK, Jeste DV, et al. 2004. Abnormal brain response of 
chronic schizophrenia patients despite a normal performance during a 
visual vigilance task. Psychiatry Res, 130:245–57.
Fletcher PC, Frith CD, Grasby PM, et al. 1996. Local and distributed 
effects of apomorphine on fronto-temporal function in acute unmedi-
cated schizophrenia. J Neurosci, 16:7055–62. 
Fletcher PC, McKenna PJ, Frith CD, et al. 1998. Brain activations in 
schizophrenia during a graded memory task studied with functional 
neuroimaging. Arch Gen Psychiatry, 55:1001–8.
Ford JM, Gray M, Whitﬁ  eld SL, et al. 2004. Acquiring and inhibiting 
prepotent responses in schizophrenia: event-related brain potentials 
and functional magnetic resonance imaging. Arch Gen Psychiatry, 
61:119–29.
Frackowiak RSJ, Friston KJ, Frith CD, et al. 2004. Mechanisms of control. 
In Frackowiak RSJ (ed). Human brain function. 2nd ed. London: Else-
vier/Academic Pr. pp. 329–62.
Frith CD, Friston KJ, Herold S, et al. 1995. Regional brain activity in chronic 
schizophrenic patients during the performance of a verbal ﬂ  uency task. 
Br J Psychiatry, 167:343–9. 
Fu CHY, Morgan K, Suckling J, et al. 2002. A functional magnetic resonance 
imaging study of overt letter verbal ﬂ  uency using a clustered acquisi-
tion sequence: greater anterior cingulate activation with increased task 
demand. Neuroimage, 17:871–9.
Fu CHY, Suckling J, Williams SC, et al. 2005. Effects of psychotic state and 
task demand on prefrontal function in schizophrenia: an fMRI study of 
overt verbal ﬂ  uency. Am J Psychiatry, 162:485–94. 
Glahn DC, Ragland JD, Abramoff A, et al. 2005. Beyond hypofrontality: a 
quantitative meta-analysis of functional neuroimaging studies of work-
ing memory in schizophrenia. Hum Brain Mapp, 25:60–9.
Harvey PD, Napolitano JA, Mao L, et al. 2003. Comparative effects of 
risperidone and olanzapine on cognition in elderly patients with 
schizophrenia or schizoaffective disorder. Int J Geriatr Psychiatry, 
18:820–9.
Haznedar MM, Buchsbaum MS, Luu C, et al. 1997. Decreased ante-
rior cingulate gyrus metabolic rate in schizophrenia. Am J Psychiatry 
154:682–4. 
Hill K, Mann L, Laws KR, et al. 2004. Hypofrontality in schizophrenia: 
a meta-analysis of functional imaging studies. Acta Psychiatr Scand, 
110:243–56.
Hofer A, Weiss EM, Golaszewski SM, et al. 2003a. An fMRI study of epi-
sodic encoding and recognition of words in patients with schizophrenia 
in remission. Am J Psychiatry, 160:911–18.
Hofer A, Weiss EM, Golaszewski SM, et al. 2003b. Neural correlates of 
episodic encoding and recognition of words in unmedicated patients 
during an acute episode of schizophrenia: a functional MRI study. Am 
J Psychiatry, 160:1802–8.
Hoffman RE, McGlashan TH. 2001. Neural network models of 
schizophrenia. Neuroscientist, 7:441–54.
Holmes AJ, MacDonald AW 3rd, Carter CS, et al. 2005. Prefrontal function-
ing during context processing in schizophrenia and major depression: 
an event-related fMRI study. Schizophr Res, 76:199–206.
Honey GD, Bullmore ET, Soni W, et al. 1999. Differences in frontal cortical 
activation by a working memory task after substitution of risperidone 
for typical antipsychotic drugs in patients with schizophrenia. Proc 
Natl Acad Sci USA, 96:13432–7.
Honey GD, Sharma T, Suckling J, et al. 2003. The functional neuroanatomy 
of schizophrenic subsyndromes. Psychol Med, 33:1007–18. 
Jansma JM, Ramsey NF, van der Wee NJ, et al. 2004. Working memory 
capacity in schizophrenia: a parametric fMRI study. Schizophr Res, 
68:159–71.
Jones HM, Brammer MJ, O’Toole M, et al. 2004. Cortical effects of quetia-
pine in ﬁ  rst-episode schizophrenia: a preliminary functional magnetic 
resonance imaging study. Biol Psychiatry, 56:938–42.
Kim JJ, Kwon JS, Park HJ, et al. 2003. Functional disconnection between the 
prefrontal and parietal cortices during working memory processing in 
schizophrenia: a [15(O)]H20 PET study. Am J Psychiatry, 160:919–23.
Kindermann SS, Brown GG, Zorrilla LE, et al. 2004. Spatial working 
memory among middle-aged and older patients with schizophrenia and 
volunteers using fMRI. Schizophr Res, 68:203–16.
Lahti AC, Holcomb HH, Medoff DR, et al. 1995. Ketamine activates 
psychosis and alters limbic blood ﬂ  ow in schizophrenia. Neuroreport, 
6:869–72. 
Lahti AC, Holcomb HH, Weiler MA, et al. 2003. Functional effects of 
antipsychotic drugs: comparing clozapine with haloperidol. Biol Psy-
chiatry, 53:601–8.
Lahti AC, Holcomb HH, Weiler MA, et al. 2004. Clozapine but not 
haloperidol re-establishes normal task-activated rCBF patterns in 
schizophrenia within the anterior cingulate cortex. Neuropsychophar-
macology, 29:171–8. 
Laurens KR, Ngan ET, Bates AT, et al. 2003. Rostral anterior cingulate 
cortex dysfunction during error processing in schizophrenia. Brain, 
126:610–22.
Liddle PF, Lane CJ, Ngan ET. 2000. Immediate effects of risperidone on cortico-
striatal-thalamic loops and the hippocampus. Br J Psychiatry, 177:402–7.
MacDonald AW 3rd, Carter CS. 2003. Event-related fMRI study of context 
processing in dorsolateral prefrontal cortex of patients with schizophre-
nia. J Abnorm Psychol, 112:689–97.
MacDonald AW 3rd, Carter CS, Kerns JG, et al. 2005. Speciﬁ  city of prefrontal 
dysfunction and context processing deﬁ  cits to schizophrenia in never-medi-
cated patients with ﬁ  rst-episode psychosis. Am J Psychiatry, 162:475–84. 
Manoach DS, Gollub RL, Benson ES, et al. 2000. Schizophrenic subjects show 
aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia 
during working memory performance. Biol Psychiatry, 48:99–109.
Manoach DS. 2003. Prefrontal cortex dysfunction during working mem-
ory performance in schizophrenia: reconciling discrepant ﬁ  ndings. 
Schizophr Res, 60:285–98. 
McGuire PK, Silbersweig DA, Murray RM, et al. 1996. Functional 
anatomy of inner speech and auditory verbal imagery. Psychol Med, 
26:29–38. 
Mendrek A, Laurens KR, Kiehl KA, et al. 2004. Changes in distributed 
neural circuitry function in patients with ﬁ  rst-episode schizophrenia. 
Br J Psychiatry, 185:205–14. 
Mendrek A, Kiehl KA, Smith AM, et al. 2005. Dysfunction of a distributed 
neural circuitry in schizophrenia patients during a working memory 
performance. Psychol Med, 35:187–96.
Menon V, Adleman NE, White CD, et al. 2001. Error-related brain activa-
tion during a Go/NoGo response inhibition task. Hum Brain Mapp, 
12:131–43.
Miller DD, Andreasen NC, O’Leary DS, et al. 2001. Comparison of the 
effects of risperidone and haloperidol on regional cerebral blood ﬂ  ow 
in schizophrenia. Biol Psychiatry, 49:704–15.
Nahas Z, George MS, Horner MD, et al. 2003. Augmenting atypical an-
tipsychotics with a cognitive enhancer (donepezil) improves regional 
brain activity in schizophrenia patients: a pilot double-blind placebo 
controlled BOLD fMRI study. Neurocase, 9:274–82.Neuropsychiatric Disease and Treatment 2007:3(1) 101
Anterior cingulate activation in schizophrenia
Neumann J, Lohmann G, Derrfuss J, et al. 2005. Meta-analysis of func-
tional imaging data using replicator dynamics. Hum Brain Mapp, 
25:165–73.
Ngan ETC, Lane CJ, Ruth TJ, et al. 2002. Immediate and delayed effects of 
risperidone on cerebral metabolism in neuroleptic naïve schizophrenic 
patients: correlations with symptom change. J Neurol Neurosurg 
Psychiatry, 72:106–10.
Owen AM, McMillan KM, Laird AR, et al. 2005. N-back working memory 
paradigm: a meta-analysis of normative functional imaging studies. 
Hum Brain Mapp, 25:46–59.
Paus T. 2001. Primate anterior cingulate cortex: where motor control, drive 
and cognition interface. Nat Rev Neurosci, 2:417–24. 
Paus T, Koski L, Caramanos Z, et al. 1998. Regional differences in the 
effects of task difﬁ  culty and motor output on blood ﬂ  ow response in 
the human anterior cingulate cortex: a review of 107 PET activation 
studies. Neuroreport, 9:R37–47.
Perlstein WM, Carter CS, Noll DC, et al. 2001. Relation of prefrontal cortex 
dysfunction to working memory and symptoms in schizophrenia. Am 
J Psychiatry, 158:1105–13. 
Perlstein WM, Dixit NK, Carter CS, et al. 2003. Prefrontal cortex dysfunc-
tion mediates deﬁ  cits in working memory and prepotent responding in 
schizophrenia. Biol Psychiatry, 53:25–38. 
Peterson BS, Skudlarski P, Gatenby JC, et al. 1999. An fMRI study of 
Stroop word-color interference: evidence for cingulate subregions 
subserving multiple distributed attentional systems. Biol Psychiatry, 
45:1237–58. 
Petit L, Courtney SM, Ungerleider LG, et al. 1998. Sustained activ-
ity in the medial wall during working memory delays. J Neurosci, 
18:9429–37.
Ragland JD, Gur RC, Lazarev MG, et al. 2000. Hemispheric activation of 
anterior and inferior prefrontal cortex during verbal encoding and recog-
nition: a PET study of healthy volunteers. Neuroimage, 11:624–33. 
Ragland JD, Gur RC, Raz J, et al. 2001. Effect of schizophrenia on fronto-
temporal activity during word encoding and recognition: a PET cerebral 
blood ﬂ  ow study. Am J Psychiatry, 158:1114–25.
Ragland JD, Gur RC, Valdez J, et al. 2004. Event-related fMRI of frontotem-
poral activity during word encoding and recognition in schizophrenia. 
Am J Psychiatry, 161:1004–15.
Rubia K, Russell T, Bullmore ET, et al. 2001. A fMRI study of reduced left 
prefrontal activation in schizophrenia during normal inhibitory function. 
Schizophr Res, 52:47–55.
Rushworth MFS, Hadland KA, Gaffan D, et al. 2003. The effect of 
cingulate cortex lesions on task switching and working memory. J 
Cogn Neurosci, 15:338–53. 
Salgado-Pineda P, Junque C, Vendrell P, et al. 2004. Decreased cerebral 
activation during CPT performance: structural and functional deﬁ  cits 
in schizophrenic patients. Neuroimage, 21:840–7. 
Schultz SK, O’Leary DS, Boles Ponto LL, et al. 2002. Age and regional cere-
bral blood ﬂ  ow in schizophrenia: age effects in anterior cingulate, frontal 
and parietal cortex. J Neuropsychiatry Clin Neurosci, 14:19–24.
Sharaﬁ   M. 2005. Comparison of classical and clozapine treatment on schizo-
phrenia using positive and negative syndrome scale of schizophrenia 
(PANSS) and SPECT imaging. Int J Med Sci, 2:79–86.
Shergill SS, Brammer MJ, Williams SCR, et al. 2000. Mapping auditory 
hallucinations in schizophrenia using functional magnetic resonance 
imaging. Arch Gen Psychiatry, 57:1033–8.
Siegel BV, Buchsbaum MS, Bunney WE, et al. 1993. Cortical-striatal-
thalamic circuits and brain glucose metabolic activity in 70 unmedicated 
male schizophrenic patients. Am J Psychiatry, 150:1325–36.
Silbersweig DA, Stern E, Frith C, et al. 1995. A functional neuroanatomy 
of hallucinations in schizophrenia. Nature, 378:176–9. 
Spence SA, Brooks DJ, Hirsch SR, et al. 1997. A PET study of voluntary 
movement in schizophrenic patients experiencing passivity phenomena 
(delusions of alien control). Brain, 120:1997–2011. 
Spence SA, Liddle PF, Stefan MD, et al. 2000. Functional anatomy of 
verbal ﬂ  uency in people with schizophrenia and those at genetic risk. 
Focal dysfunction and distributed dysconnectivity reappraised. Br J 
Psychiatry, 176:52–60. 
Spence SA, Green RD, Wilkinson ID, et al. 2005. Modaﬁ  nil modulates 
anterior cingulate function in chronic schizophrenia. Br J Psychiatry, 
187:55–61. 
Thermenos HW, Goldstein JM, Buka SL, et al. 2005. The effect of working 
memory performance on functional MRI in schizophrenia. Schizophr 
Res, 74:179–94. 
van Hoesen GW, Morecraft RJ, Vogt BA. 1993. Connections of the monkey 
cingulate cortex. In: Vogt BA and Gabriel M (eds). Neurobiology 
of cingulate cortex and limbic thalamus. Berlin: Birkhauser 
pp. 249–84. 
Velligan DI, Newcomer J, Pultz J, et al. 2002. Does cognitive function 
improve with quetiapine in comparison to haloperidol. Schizophr Res, 
53:239–48. 
Vogt BA. 2005. Pain and emotion interactions in subregions of the cingulate 
gyrus. Nature Reviews Neuroscience, 6:533–44.
Volz H, Gaser C, Hager F, et al. 1999. Decreased frontal activation in 
schizophrenics during stimulation with the continuous performance 
test—a functional magnetic resonance imaging study. Eur Psychiatry, 
14:17–24.
Walter H, Wunderlich AP, Blankenhorn M, et al. 2003. No hypofrontality, 
but absence of prefrontal lateralization comparing verbal and spatial 
working memory in schizophrenia. Schizophr Res, 61:175–84.
Weiss EM, Golaszewski S, Mottaghy FM, et al. 2003. Brain activation 
patterns during a selective attention test—a functional MRI study in 
healthy volunteers and patients with schizophrenia. Psychiatry Res, 
123:1–15.
Wykes T, Brammer M, Mellers J, et al. 2002. Effects on the brain of a 
psychological treatment: cognitive remediation therapy. Br J Psychiatry, 
181:144–52.
Yucel M, Pantelis C, Stuart GW, et al. 2002. Anterior cingulate activation 
during Stroop task performance: a PET to MRI coregistration study of 
individual patients with schizophrenia. Am J Psychiatry, 159:251–4.